• Open Access IconOpen Access
  • Cite Icon166
  • https://doi.org/10.1002/14651858.cd005195.pub3Copy DOI Icon

Selenium for preventing cancer.

Show More
  • Abstract
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

This review is an update of the first Cochrane publication on selenium for preventing cancer (Dennert 2011).Selenium is a metalloid with both nutritional and toxicological properties. Higher selenium exposure and selenium supplements have been suggested to protect against several types of cancers. Two research questions were addressed in this review: What is the evidence for:1. an aetiological relation between selenium exposure and cancer risk in humans? and2. the efficacy of selenium supplementation for cancer prevention in humans? We conducted electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL, 2013, Issue 1), MEDLINE (Ovid, 1966 to February 2013 week 1), EMBASE (1980 to 2013 week 6), CancerLit (February 2004) and CCMed (February 2011). As MEDLINE now includes the journals indexed in CancerLit, no further searches were conducted in this database after 2004. We included prospective observational studies (cohort studies including sub-cohort controlled studies and nested case-control studies) and randomised controlled trials (RCTs) with healthy adult participants (18 years of age and older). For observational studies, we conducted random effects meta-analyses when five or more studies were retrieved for a specific outcome. For RCTs, we performed random effects meta-analyses when two or more studies were available. The risk of bias in observational studies was assessed using forms adapted from the Newcastle-Ottawa Quality Assessment Scale for cohort and case-control studies; the criteria specified in the Cochrane Handbook for Systematic Reviews of Interventions were used to evaluate the risk of bias in RCTs. We included 55 prospective observational studies (including more than 1,100,000 participants) and eight RCTs (with a total of 44,743 participants). For the observational studies, we found lower cancer incidence (summary odds ratio (OR) 0.69, 95% confidence interval (CI) 0.53 to 0.91, N = 8) and cancer mortality (OR 0.60, 95% CI 0.39 to 0.93, N = 6) associated with higher selenium exposure. Gender-specific subgroup analysis provided no clear evidence of different effects in men and women (P value 0.47), although cancer incidence was lower in men (OR 0.66, 95% CI 0.42 to 1.05, N = 6) than in women (OR 0.90, 95% CI 0.45 to 1.77, N = 2). The most pronounced decreases in risk of site-specific cancers were seen for stomach, bladder and prostate cancers. However, these findings have limitations due to study design, quality and heterogeneity that complicate interpretation of the summary statistics. Some studies suggested that genetic factors may modify the relation between selenium and cancer risk-a hypothesis that deserves further investigation.In RCTs, we found no clear evidence that selenium supplementation reduced the risk of any cancer (risk ratio (RR) 0.90, 95% CI 0.70 to 1.17, two studies, N = 4765) or cancer-related mortality (RR 0.81, 95% CI 0.49 to 1.32, two studies, N = 18,698), and this finding was confirmed when the analysis was restricted to studies with low risk of bias. The effect on prostate cancer was imprecise (RR 0.90, 95% CI 0.71 to 1.14, four studies, N = 19,110), and when the analysis was limited to trials with low risk of bias, the interventions showed no effect (RR 1.02, 95% CI 0.90 to 1.14, three studies, N = 18,183). The risk of non-melanoma skin cancer was increased (RR 1.44, 95% CI 0.95 to 1.17, three studies, N = 1900). Results of two trials-the Nutritional Prevention of Cancer Trial (NPCT) and the Selenium and Vitamin E Cancer Trial (SELECT)-also raised concerns about possible increased risk of type 2 diabetes, alopecia and dermatitis due to selenium supplements. An early hypothesis generated by NPCT that individuals with the lowest blood selenium levels at baseline could reduce their risk of cancer, particularly of prostate cancer, by increasing selenium intake has not been confirmed by subsequent trials. As the RCT participants were overwhelmingly male (94%), gender differences could not be systematically assessed. Although an inverse association between selenium exposure and the risk of some types of cancer was found in some observational studies, this cannot be taken as evidence of a causal relation, and these results should be interpreted with caution. These studies have many limitations, including issues with assessment of exposure to selenium and to its various chemical forms, heterogeneity, confounding and other biases. Conflicting results including inverse, null and direct associations have been reported for some cancer types.RCTs assessing the effects of selenium supplementation on cancer risk have yielded inconsistent results, although the most recent studies, characterised by a low risk of bias, found no beneficial effect on cancer risk, more specifically on risk of prostate cancer, as well as little evidence of any influence of baseline selenium status. Rather, some trials suggest harmful effects of selenium exposure. To date, no convincing evidence suggests that selenium supplements can prevent cancer in humans.

Similar Papers
  • Discussion
  • Citations6

Can selenium supplementation prevent colorectal cancer?

  • Nov 01, 2006
  • Gastroenterology
  • Steven B Ingle +1
  • PDF
  • Supplementary Content
  • Citations27

Selenium for preventing cancer

  • Jan 01, 2012
  • São Paulo Medical Journal
  • Gabriele Dennert +5
  • Research Article
  • Citations524

Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial.

  • Apr 16, 2003
  • BJU International
  • A.J Duffield‐Lillico +7
  • PDF
  • Research Article

Diet and health. What can you believe: or does bacon kill you?

  • Jan 01, 2015
  • The Winnower
  • David Colquhoun
  • Research Article
  • Citations9

Interventions for the prevention of postoperative ear discharge after insertion of ventilation tubes (grommets) in children

  • Aug 01, 2013
  • Clinical Otolaryngology
  • Mohammed Iqbal Syed +3
  • Research Article
  • Citations266

Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.

  • Oct 19, 2020
  • The Cochrane database of systematic reviews
  • Stephanie Weibel +14
  • Research Article
  • Citations21

Safety and Efficacy of Vinpocetine as a Neuroprotective Agent in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.

  • Apr 29, 2022
  • Neurocritical Care
  • Prateek Kumar Panda +3
  • PDF
  • Research Article
  • Citations9

Assessing the risk of bias in randomized controlled trials in the field of dentistry indexed in the Lilacs (Literatura Latino-Americana e do Caribe em Ciências da Saúde) database.

  • Mar 01, 2011
  • Sao Paulo medical journal = Revista paulista de medicina
  • Christiane Alves Ferreira +3
  • Research Article
  • Citations338

Electronic cigarettes for smoking cessation.

  • Apr 29, 2021
  • Cochrane Database of Systematic Reviews
  • Jamie Hartmann-Boyce +11
  • Research Article
  • Citations442

Electronic cigarettes for smoking cessation.

  • Oct 14, 2020
  • The Cochrane database of systematic reviews
  • Jamie Hartmann-Boyce +10
  • Research Article
  • Citations20

Rituximab for thyroid-associated ophthalmopathy.

  • Jun 16, 2022
  • The Cochrane database of systematic reviews
  • Swan Kang +3
  • Research Article

The Efficacy and Safety of Tolvaptan in Heart Failure Patients with Congestive Signs: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  • Nov 10, 2022
  • Cardiology Discovery
  • Mei Zeng +5
  • Research Article
  • Citations107

Surgery for women with apical vaginal prolapse.

  • Jul 26, 2023
  • The Cochrane database of systematic reviews
  • Christopher Maher +6
  • Research Article
  • Citations159

Colchicine for acute gout.

  • Aug 15, 2014
  • The Cochrane database of systematic reviews
  • Irene Van Echteld +4
  • Research Article
  • Citations4

First aid glucose administration routes for symptomatic hypoglycaemia

  • Mar 07, 2019
  • Cochrane Database of Systematic Reviews
  • Emmy De Buck +5
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.